Genomic Selection Platform Market Valued to Reach USD $4.25 Billion by 2029 at 16.9% CAGR

 Save 30% on All Global Market Reports With Code ONLINE30 — Gain Insights Into Tariffs, Inflation, and Industry Trends

 

 What Is the Growth Potential of the Genomic Selection Platform Market in the Next Decade?
 The genomic selection platform market size has grown rapidly in recent years. It will grow from $1.94 billion in 2024 to $2.27 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to the growth of agricultural biotechnology, the rise of quantitative genetics in breeding programs, an increase in focus on disease resistance in crops and livestock, expansion of collaborative research programs, and rising disease pressures and climate variability.
 
 The genomic selection platform market size is expected to see rapid growth in the next few years. It will grow to $4.25 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to rising global food demand, growth of precision agriculture, increasing focus on sustainable breeding, expansion of livestock genomics, and growth of contract breeding and genomic services. Major trends in the forecast period include advancements in next-generation sequencing (NGS), integration with digital agriculture tools, AI and machine learning integration, adoption of cloud-based genomic data platforms, and multi-omics data integration.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp
 
 What Are the Leading Growth Factors in the Genomic Selection Platform Market?
 The increasing adoption of personalized medicine is expected to propel the growth of the genomic selection platform market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Genomic selection platforms support personalized medicine by providing precise genomic insights, making them ideal for tailoring treatments to individual patients. They reduce trial-and-error in therapy selection by predicting responses to interventions, improving treatment effectiveness and patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the genomic selection platform market.
 
 Increasing Crop Yields Fueling The Growth Of The Market Due To Enhancing Agricultural Productivity And Efficient Breeding
 
 The increasing crop yields are expected to drive the growth of the genomic selection platform market going forward. Crop yield is the amount of agricultural output (such as grains, fruits, or vegetables) produced per unit of land. Crop yield is rising due to advances in agricultural biotechnology that enhance plant genetics and resilience. Genomic selection platforms enhance crop yields by enabling precise selection of high-performing plant varieties, making them ideal for modern agriculture and breeding programs. They reduce the time and cost of traditional breeding by providing accurate genetic predictions, improving farm productivity and food security. For instance, in February 2024, according to the Department for Environment, Food and Rural Affairs, a UK-based government agency, the UK’s total cereal production, including wheat, barley, oats, and minor cereals (such as rye, triticale, and mixed grain), reached 24.3 million tonnes in 2022, an 8% increase from 2021. Therefore, the increasing crop yields are driving the growth of the genomic selection platform market.
 
 Which Segment Offers the Highest Growth Opportunities in the Genomic Selection Platform Market?
 The genomic selection platform market covered in this report is segmented as
 
 1) By Component: Software, Hardware, Services
 2) By Deployment Mode: On-Premises, Cloud-Based
 3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications
 4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End Users
 
 Subsegments:
 1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools
 2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics
 3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting & Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services
 
 Which Trends Are Most Likely to Influence Genomic Selection Platform Market Growth in the Next Decade?
 Major companies operating in the genomic selection platform market are focusing on developing innovative solutions, such as targeted sequencing platforms, to improve trait prediction and accelerate breeding programs. Targeted sequencing platforms refer to genomic technologies and systems designed to sequence specific regions of the genome rather than the entire genome. For instance, in October 2024, Element Biosciences Inc., a US-based life sciences technology company, launched Trinity, a breakthrough targeted sequencing platform that streamlines exome capture by integrating traditionally complex steps directly into its AVITI System. The platform eliminates the need for specialized equipment, reduces manual work by up to five hours, and offers a one-hour hybridization option for same-day results, making it ideal for time-sensitive studies. Trinity expands to support custom panels across diverse applications such as oncology, respiratory diseases, and minimal residual disease (MRD). It delivers faster, more cost-effective, and more accessible sequencing, marking the first major advancement in exome capture.
 
 Who Are the Leading Companies in the Genomic Selection Platform Industry by Revenue?
 
 Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., and Enigma Genomics Inc.
 
 Get the full genomic selection platform market report here:
 https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report
 
 What Are the Regional Opportunities for Investment in the Genomic Selection Platform Market?
 North America was the largest region in the genomic selection platform market in 2024. The regions covered in genomic selection platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company